pp 3-18 Editing the Epigenome: Overview, Open Questions, and Directions of Future Development. Rots MG, Jeltsch A.

pp 19-63 Zinc Fingers, TALEs, and CRISPR Systems: A Comparison of Tools for Epigenome Editing. Waryah C.B, Moses, Arooj M, Blancafort P.

pp 137-146 Allele-Specific Epigenome Editing. Bashtrykov P, Jeltsch A.

pp 167-185 CRISPR/dCas9 Switch Systems for Temporal Transcriptional Control. Gjaltema RAF, Schulz EG.

pp 215-225 Stable Expression of Epigenome Editors via Viral Delivery and Genomic Integration. Kroll C., Rathert P.

pp 227-239 Purified Protein Delivery to Activate an Epigenetically Silenced Allele in Mouse Brain. Pyles B, Bailus BJ, O’Geen H, Segal DJ.

pp 241-254 Non-viral Methodology for Efficient Co-transfection. Kretzmann JA, Evans CW, Norret M, Blancafort P, Swaminathan Iyer K.

pp 419-428 Editing of DNA Methylation Using dCas9-Peptide Repeat and scFv-TET1 Catalytic Domain Fusions. Morita S, Horii T, Hatada I.

pp 429-445 Chemical Inducible dCas9-Guided Editing of H3K27 Acetylation in Mammalian Cells. Gao D, Liang FS.      

pp 447-480 Screening Regulatory Element Function with CRISPR/Cas9-based Epigenome Editing.  Klann TS, Crawford GE, Reddy TE, Gersbach CA.